A Mutation That Prevents Proper Opioid Peptide Processing Causes Obesity in Mice | Research

The takeaway

Mice with defective carboxypeptidase E (CPE) had impaired processing of multiple opioid and appetite peptides, linking peptide processing dysfunction to obesity development.

Multi-peptide disruption
One enzyme defect impaired processing of dynorphin, enkephalin, and other peptide hormones simultaneously — obesity from broken peptide machinery

What the researchers found

CPE-fat mice showed impaired prohormone convertase activity resulting in defective processing of opioid peptides (prodynorphin, proenkephalin) and other peptide hormones, linking peptide processing dysfunction to obesity.

Why it matters

Obesity may not always be about overeating or inactivity — it can result from fundamental defects in how the body processes peptide hormones. This shifts the understanding from behavior to biology.

How the study worked

Animal study in CPE-fat/CPE-fat mice analyzing prohormone processing. Multiple peptide precursor and product forms measured in brain and endocrine tissues to assess processing efficiency.

What this study cannot tell us

Single gene mutation model. CPE-fat mice develop obesity late, suggesting compensatory mechanisms exist. The relative contribution of different peptide processing defects to obesity was not determined.

How to read the evidence

Preliminary animal evidence from a genetic model with clear molecular characterization of peptide processing defects.

When this study was published

Published in 2001. Human CPE variants have been associated with obesity, validating the relevance of this mouse model.

The bigger picture

Peptide hormones must be properly processed from their precursors to function. A single processing enzyme defect can disrupt multiple hormonal systems simultaneously — appetite, pain, mood — causing complex disease.

Questions still open

Do humans with CPE variants develop obesity?
Which misprocessed peptide is most important for the obesity phenotype?
Could enzyme replacement or peptide supplementation prevent obesity in this model?

Common questions

Can a processing defect cause obesity?

Yes. This study shows mice with a broken peptide-processing enzyme developed obesity because they couldn't properly produce the hormones that regulate appetite, metabolism, and energy balance.

Does this happen in humans?

Human variants in the CPE gene have been associated with obesity, suggesting the same mechanism operates in people. This shifts some obesity from a behavioral problem to a biochemical one.

Read the original research

Impaired prohormone convertases in Cpe(fat)/Cpe(fat) mice.

The Journal of biological chemistry, 276(2), 1466-73

View on PubMed ↗

Citation

Berman, Y; Mzhavia, N; Polonskaia, A; Devi, L A. (2001). Impaired prohormone convertases in Cpe(fat)/Cpe(fat) mice.. The Journal of biological chemistry, 276(2), 1466-73.